Samsung To Reportedly Level Up Its Health Tech Game — Plans To Challenge Apple With Noninvasive Blood Sugar Monitoring
Portfolio Pulse from Ananya Gairola
Samsung Electronics Co. is entering the health tech sector with noninvasive glucose and continuous blood pressure monitoring technology, challenging Apple Inc. and other tech giants. Samsung plans to integrate health features into various devices, including the Galaxy Ring. The company is also enhancing its blood pressure features and exploring new sensors for earbuds. Apple, facing an IP dispute with Masimo Corporation, had to remove the blood oxygen feature from its latest Apple Watch models in the U.S. This intensifies the competition between Samsung and Apple, who recently surpassed Samsung in global smartphone shipments.
January 23, 2024 | 1:47 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apple's recent IP dispute with Masimo and the removal of the blood oxygen feature from its latest watches in the U.S. could negatively impact its stock in the short term.
The removal of a key health feature from Apple's latest watches due to an IP dispute could be seen as a setback, potentially affecting consumer perception and sales in the short term.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
As a competitor in the health tech space, Alphabet Inc. may experience indirect impact from Samsung's new health tech initiatives and Apple's legal challenges.
Alphabet, through its various health tech ventures, may be indirectly affected by the competitive dynamics between Samsung and Apple, although the direct impact is less clear.
CONFIDENCE 60
IMPORTANCE 30
RELEVANCE 40
NEUTRAL IMPACT
Alphabet Inc.'s stock may see an indirect impact due to the evolving competitive landscape in the health tech sector influenced by Samsung's and Apple's moves.
Alphabet's involvement in health tech means it could be indirectly impacted by the competition and legal issues affecting Samsung and Apple, though the direct impact is uncertain.
CONFIDENCE 60
IMPORTANCE 30
RELEVANCE 40
NEUTRAL IMPACT
Masimo's IP dispute with Apple, leading to the removal of the blood oxygen feature from Apple Watch models, could have a mixed impact on its stock as it asserts its patents.
While asserting IP rights can be positive, the outcome of the dispute and potential counteractions by Apple could introduce uncertainty affecting Masimo's stock.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Samsung's push into health tech with new features may boost its competitive edge and attract health-conscious consumers, potentially impacting its stock positively.
Samsung's announcement of entering the health tech market with innovative features could be seen as a positive development, likely to attract consumer interest and potentially increase market share against competitors.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80